226 related articles for article (PubMed ID: 25420811)
21. Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy.
Bosch W; Poowanawittayakom N; Chaikriangkrai K; Mendez J; Hellinger WC; Gonwa TA; Krishna M; Pungpapong S
Transpl Infect Dis; 2013 Feb; 15(1):E33-9. PubMed ID: 23278987
[TBL] [Abstract][Full Text] [Related]
22. Alemtuzumab induction with tacrolimus monotherapy in 25 pediatric renal transplant recipients.
Sung J; Barry JM; Jenkins R; Rozansky D; Iragorri S; Conlin M; Al-Uzri A
Pediatr Transplant; 2013 Dec; 17(8):718-25. PubMed ID: 24164824
[TBL] [Abstract][Full Text] [Related]
23. Endemic and opportunistic infections in Brazilian solid organ transplant recipients.
Batista MV; Pierrotti LC; Abdala E; Clemente WT; Girão ES; Rosa DR; Ianhez LE; Bonazzi PR; Lima AS; Fernandes PF; Pádua-Neto MV; Bacchella T; Oliveira AP; Viana CF; Ferreira MS; Shikanai-Yasuda MA
Trop Med Int Health; 2011 Sep; 16(9):1134-42. PubMed ID: 21692958
[TBL] [Abstract][Full Text] [Related]
24. Alemtuzumab induction in renal transplantation.
Hanaway MJ; Woodle ES; Mulgaonkar S; Peddi VR; Kaufman DB; First MR; Croy R; Holman J;
N Engl J Med; 2011 May; 364(20):1909-19. PubMed ID: 21591943
[TBL] [Abstract][Full Text] [Related]
25. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
Lü TM; Yang SL; Wu WZ; Tan JM
Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and outcome of systemic fungal infections in renal transplant recipients - A tertiary care experience.
Shekar M; Elumalai R; Elayaperumal I; Yelahanka RP; Anandkumar DG; Bandi VK; Matcha J
Saudi J Kidney Dis Transpl; 2019; 30(5):1137-1143. PubMed ID: 31696853
[TBL] [Abstract][Full Text] [Related]
27. Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression.
Schwartz JJ; Ishitani MB; Weckwerth J; Morgenstern B; Milliner D; Stegall MD
Transplantation; 2007 Sep; 84(6):715-21. PubMed ID: 17893604
[TBL] [Abstract][Full Text] [Related]
28. Nocardiosis in renal transplant patients.
Gibson M; Yang N; Waller JL; Young L; Bollag WB; Kheda M; Mohammed A; Baer SL
J Investig Med; 2022 Jan; 70(1):36-45. PubMed ID: 34426458
[TBL] [Abstract][Full Text] [Related]
29. Expanding the horizons of histoplasmosis: disseminated histoplasmosis in a renal transplant patient after a trip to Bangladesh.
Rappo U; Beitler JR; Faulhaber JR; Firoz B; Henning JS; Thomas KM; Maslow M; Goldfarb DS; Horowitz HW
Transpl Infect Dis; 2010 Apr; 12(2):155-60. PubMed ID: 19878490
[TBL] [Abstract][Full Text] [Related]
30. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
Agarwal SK; Bhowmik D; Mahajan S; Bagchi S
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825
[TBL] [Abstract][Full Text] [Related]
31. 5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation.
Stratta RJ; Rogers J; Orlando G; Farooq U; Al-Shraideh Y; Farney AC
Transplant Proc; 2014; 46(6):1928-31. PubMed ID: 25131073
[TBL] [Abstract][Full Text] [Related]
32. Cytomegalovirus infection in renal transplant recipients: one center's experience.
Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
[TBL] [Abstract][Full Text] [Related]
33. Disseminated histoplasmosis in a renal transplant patient: a cause of renal failure several years following transplantation.
Sridhar NR; Tchervenkov JI; Weiss MA; Hijazi YM; First MR
Am J Kidney Dis; 1991 Jun; 17(6):719-21. PubMed ID: 2042657
[TBL] [Abstract][Full Text] [Related]
34. Effect of steroid-free low concentration calcineurin inhibitor maintenance immunosuppression regimen on renal allograft histopathology and function.
Nainani N; Patel N; Tahir N; Kumar R; Weber-Shrikant E; Gundroo AA; Murray BM; Tornatore KM; Blessios GA; Venuto RC
Nephrol Dial Transplant; 2012 May; 27(5):2077-83. PubMed ID: 22058172
[TBL] [Abstract][Full Text] [Related]
35. Basiliximab: a review of its use as induction therapy in renal transplantation.
Chapman TM; Keating GM
Drugs; 2003; 63(24):2803-35. PubMed ID: 14664658
[TBL] [Abstract][Full Text] [Related]
36. Is pulmonary histoplasmosis a risk factor for acute renal failure in renal transplant recipients?
Pourfarziani V; Taheri S
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):643-5. PubMed ID: 19587508
[TBL] [Abstract][Full Text] [Related]
37. High impact of rejection therapy on the incidence of post-transplant diabetes mellitus after kidney transplantation.
Schweer T; Gwinner W; Scheffner I; Schwarz A; Haller H; Blume C
Clin Transplant; 2014 Apr; 28(4):512-9. PubMed ID: 24649873
[TBL] [Abstract][Full Text] [Related]
38. A retrospective study to describe the epidemiology and outcomes of opportunistic infections after abdominal organ transplantation.
Helfrich M; Dorschner P; Thomas K; Stosor V; Ison MG
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273393
[TBL] [Abstract][Full Text] [Related]
39. Polyomavirus nephropathy after renal transplantation: a single centre experience.
Kim HC; Hwang EA; Han SY; Park SB; Park KK
Nephrology (Carlton); 2005 Apr; 10(2):198-203. PubMed ID: 15877682
[TBL] [Abstract][Full Text] [Related]
40. Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial.
Krämer BK; Klinger M; Vítko Š; Glyda M; Midtvedt K; Stefoni S; Citterio F; Pietruck F; Squifflet JP; Segoloni G; Krüger B; Sperschneider H; Banas B; Bäckman L; Weber M; Carmellini M; Perner F; Claesson K; Marcinkowski W; Ostrowski M; Senatorski G; Nordström J; Salmela K
Transplantation; 2012 Sep; 94(5):492-8. PubMed ID: 22858806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
